06/08/2026
Dear Investor,
You've seen it on celebrities, athletes, politicians - maybe even a few of your friends.
They suddenly take on the sunken, wrinkled appearance of someone ten or twenty years older. Their cheeks hollow out. Their skin looks deflated. Their face seems to collapse inward.
But they haven't aged.
They've just started using a GLP‑1 drug like Ozempic, Wegovy, or Mounjaro... and while they're losing weight at record speed, they're also winding up with what many are now calling "Ozempic face."
And now many are looking for a solution to this emerging issue.
As a result, some individuals affected by Ozempic face are spending significant amounts on treatments such as Botox, fillers, hyaluronic acid, and biostimulators, as they try to get back to looking like themselves.
In fact, according to the Boston Consulting Group the revenue generated for these treatments thanks to GLP-1 side effects will more than double over the next five years to $2 billion.
But here's the issue... when it comes to Ozempic face, these products - which are often used to address wrinkles - may not offer a long-term solution for everyone.
They may add volume to the skin for a period of time, but they are not designed to rebuild tissue affected by rapid weight loss.
That has created a potentially significant market for new products intended to address Ozempic face.......................
